Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
VET | Ann: Outstanding ETF Securities Announcement | 05/04/24 | 0 | 77 | |||
|
|||||||
VET | Ann: Distribution Tax Estimates | 03/04/24 | 0 | 120 | |||
|
|||||||
VET | Ann: DRP Issue Price Announcement for the period ended 31 Mar 24 | 03/04/24 | 0 | 77 | |||
|
|||||||
VET | Ann: Final Distribution Announcement | 03/04/24 | 0 | 66 | |||
|
|||||||
VET | Ann: Updated Estimated Distribution Announcement | 02/04/24 | 0 | 79 | |||
|
|||||||
VET | Ann: Estimated Distribution Announcement | 26/03/24 | 0 | 76 | |||
|
|||||||
VET | Ann: Distribution Timetable Announcement | 21/03/24 | 0 | 84 | |||
|
|||||||
VET | Ann: Interim Report | 13/03/24 | 0 | 91 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |